Arteris (AIP) Form 144: 6,421 Shares Proposed Sale $87,197

Arteris, Inc. filing a Form 144 notifies a proposed sale of 6,421 common shares (acquired as restricted stock units) with an aggregate market value of $87,197.18, through Morgan Stanley Smith Barney LLC on or about 10/07/2025.

Rhea-AI Filing Summary

Arteris, Inc. filing a Form 144 notifies a proposed sale of 6,421 common shares (acquired as restricted stock units) with an aggregate market value of $87,197.18, through Morgan Stanley Smith Barney LLC on or about 10/07/2025. The RSUs were recorded as acquired on 10/01/2025 and the filing lists previous sales by the same person totaling 30,538 shares during the prior three months, generating gross proceeds of $336,546.61. The filer affirms no undisclosed material adverse information and references Rule 10b5-1 sales plans used for several prior transactions.

Positive

• Transaction transparency: Filing discloses the proposed sale amount and broker (Morgan Stanley Smith Barney LLC)
• Source of shares clear: Shares to be sold were acquired as Restricted Stock Units on 10/01/2025

Negative

• Significant insider selling: 30,538 shares sold in prior three months for gross proceeds of $336,546.61
• Additional near-term sale: Proposed sale of 6,421 shares on or about 10/07/2025, increasing insider supply

Insights

Corporate Insider Transactions Analyst

TL;DR: Insider proposes sale of RSUs and has executed material sales recently.

The filing shows a proposed sale of 6,421 shares acquired as restricted stock units on 10/01/2025

Prior sales by the same person total 30,538 shares for gross proceeds of $336,546.61 over the past three months, with multiple trades executed under 10b5-1 plans. The immediate dependency is the timing noted as "approximate date of sale" 10/07/2025, and execution will occur via Morgan Stanley Smith Barney LLC.

Watch for the actual execution on 10/07/2025 and any subsequent amendment disclosing a different sale amount or cancellation; continued selling at this scale relative to outstanding shares could be meaningful to supply, though no financial performance metrics are provided here.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Arteris (AIP) Form 144 report?

The Form 144 reports a proposed sale of 6,421 common shares (RSUs) valued at $87,197.18, with an approximate sale date of 10/07/2025.

Who will execute the sale on Form 144 for AIP?

The filing lists Morgan Stanley Smith Barney LLC as the broker handling the proposed sale.

Were there recent insider sales by the same person at Arteris (AIP)?

Yes. The filing shows the person sold a total of 30,538 shares in the prior three months, receiving gross proceeds of $336,546.61.

What is the acquisition method for the shares being sold?

The shares were acquired as Restricted Stock Units on 10/01/2025.

Does the filer assert any undisclosed material information?

By signing, the filer represents they do not know any material adverse information about the issuer that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/07/2025 - 04:19 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001549550
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Arteris, Inc.
SEC File Number	001-40960
Address of Issuer	900 E. Hamilton Ave., Suite 300 Campbell CALIFORNIA 95008
Phone	4084707300
Name of Person for Whose Account the Securities are To Be Sold	NICHOLAS HAWKINS
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	6421	87197.18	42649917	10/07/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/01/2025	Restricted Stock Units	Issuer			6421	10/01/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
NICHOLAS HAWKINS 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	10/02/2025	3887	42449.15
10b5-1 Sales Plan for NICHOLAS HAWKINS 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	09/09/2025	3660	31806.50
NICHOLAS HAWKINS 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	09/02/2025	438	3872.66
10b5-1 Sales Plan for NICHOLAS HAWKINS 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	08/05/2025	11276	148285.04
10b5-1 Sales Plan for NICHOLAS HAWKINS 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	08/01/2025	5638	50926.93
10b5-1 Sales Plan for NICHOLAS HAWKINS 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	07/29/2025	5638	59206.33

144: Remarks and Signature

Remarks
Date of Notice	10/07/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/04/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ NICHOLAS HAWKINS
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)